Key result
Reinvigorating myofilament research requires advanced technologies and interdisciplinary collaboration to translate basic science discoveries into clinical therapies for cardiomyopathies.
Answers are grounded in this paper and cite their sources.
In the not too distant past, myofilament research attracted considerable attention after the discovery that mutations in myofilament genes cause cardiomyopathies. However, basic research has not been completely translated into therapies. This viewpoint discusses the need to develop innovative and integrative technologies and generate translatable models to uncover the complex biology of myofilament proteins to advance the field.
No takes yet. Share an insight, caveat, or question.
Sakthivel Sadayappan (2017) conducted an editorial in Cardiomyopathies. Reinvigorating myofilament research requires advanced technologies and interdisciplinary collaboration to translate basic science discoveries into clinical therapies for cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: